V

VILIN BIO MED LIMITED

VILINBIONSE
Market snapshot · 2026-08-10 22:36 UTC

41.90

₹-2.15 (-4.88%)

MARKET CAP

STOCK P/E

52W HIGH

₹41.90

52W LOW

₹41.90

BOOK VALUE

EPS

ROE

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

4,000

P/B RATIO

PEG RATIO

Sector

Healthcare

Themes

Pharmaceuticals & Biotechnology
₹42.90₹42.65₹42.40₹42.15₹41.90VolumeAug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for VILINBIO.

Coverage check

Price Forecast

Current
₹41.90
High Target
Median Target
Low Target
Price history (1Y)
Analyst target range

Probabilistic Range

Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.

Time horizonRange ()Probability
3M₹33.38 - ₹63.6380%
6M₹32.12 - ₹79.9880%
12M₹32.17 - ₹116.8880%
Realized vol: +50.3% · Drift: +50.7%

Revenue Forecast

₹ Cr
PastCurrent

EPS Forecast

₹ / share
PastCurrent
Analyst price target unavailable from FMP/yfinance. EPS forecast unavailable from FMP/yfinance. Revenue forecast unavailable from FMP/yfinance. Analyst recommendation consensus unavailable from FMP/yfinance. Fundamentals pillar unavailable from supplied financials. Valuation pillar unavailable from supplied valuation. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Mixed
46%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Unavailable

No usable capital-efficiency, cash-conversion, or growth inputs were supplied.

Valuation

Unavailable

No valid valuation metrics were supplied.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Weak Structure

Technicals institutional score is 42 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.

Market Sentiment

Neutral backdrop

Recent news flow is balanced or not decisive enough to tilt the tape. Based on 1 recent ticker-linked news items.

Signal Summary

Market intelligence remains Mixed. Available evidence provides partial support, while technical structure and market sentiment remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Technical Structure Weak StructureMarket Sentiment Neutral backdrop

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical Score43%
Fundamental ScoreUnavailable
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

Historical valuation metrics are unavailable for this ticker right now.

Peers & Comparison

Sector: Healthcare · Theme: Pharmaceuticals & Biotechnology

No peer data available for this company.
WHY THESE PEERS

Peers are filtered to companies with market cap between 0.2x and 5.0x of the primary company.

Financials

Financial chart data is not available for this company right now.

Results

Income statement data not available.

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters63.89%63.89%63.89%63.65%59.57%
Public34.18%33.49%33.55%33.96%30.19%
Others1.93%2.62%2.56%2.39%10.24%
Mar 2026
Promoters
Public
Others